These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7802645

  • 1. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC, Lugo A, Walsky R, Visnick M, Coffey JW, Fotouhi N.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1156-63. PubMed ID: 7802645
    [Abstract] [Full Text] [Related]

  • 2. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP.
    Lab Invest; 1994 Jun 15; 70(6):800-6. PubMed ID: 8015284
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
    Odake S, Morita Y, Morikawa T, Yoshida N, Hori H, Nagai Y.
    Biochem Biophys Res Commun; 1994 Mar 30; 199(3):1442-6. PubMed ID: 8147888
    [Abstract] [Full Text] [Related]

  • 4. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins.
    Docherty AJ, Murphy G.
    Ann Rheum Dis; 1990 Jun 30; 49 Suppl 1():469-79. PubMed ID: 2197998
    [Abstract] [Full Text] [Related]

  • 5. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 30; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 6. Structure-function relationships in the tissue inhibitors of metalloproteinases.
    Willenbrock F, Murphy G.
    Am J Respir Crit Care Med; 1994 Dec 30; 150(6 Pt 2):S165-70. PubMed ID: 7952654
    [Abstract] [Full Text] [Related]

  • 7. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G.
    Biochemistry; 1994 Mar 01; 33(8):2089-95. PubMed ID: 8117665
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
    Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE.
    J Med Chem; 1999 Jan 14; 42(1):87-94. PubMed ID: 9888835
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
    Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W.
    Nature; 1997 Sep 04; 389(6646):77-81. PubMed ID: 9288970
    [Abstract] [Full Text] [Related]

  • 10. Dynamic characterisation of the netrin-like domain of human type 1 procollagen C-proteinase enhancer and comparison to the N-terminal domain of tissue inhibitor of metalloproteinases (TIMP).
    Williamson RA, Panagiotidou P, Mott JD, Howard MJ.
    Mol Biosyst; 2008 May 04; 4(5):417-25. PubMed ID: 18414739
    [Abstract] [Full Text] [Related]

  • 11. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 12. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
    Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD.
    Protein Sci; 1995 Oct 01; 4(10):1966-76. PubMed ID: 8535233
    [Abstract] [Full Text] [Related]

  • 13. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.
    Tuuttila A, Morgunova E, Bergmann U, Lindqvist Y, Maskos K, Fernandez-Catalan C, Bode W, Tryggvason K, Schneider G.
    J Mol Biol; 1998 Dec 11; 284(4):1133-40. PubMed ID: 9837731
    [Abstract] [Full Text] [Related]

  • 14. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
    Pinto AF, Terra RM, Guimarães JA, Kashiwagi M, Nagase H, Serrano SM, Fox JW.
    Biochem Biophys Res Commun; 2006 Sep 01; 347(3):641-8. PubMed ID: 16842758
    [Abstract] [Full Text] [Related]

  • 15. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.
    Murphy G.
    Matrix Suppl; 1992 Sep 01; 1():323-4. PubMed ID: 1480052
    [No Abstract] [Full Text] [Related]

  • 16. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 17. Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation.
    Nomura K, Shimizu T, Kinoh H, Sendai Y, Inomata M, Suzuki N.
    Biochemistry; 1997 Jun 10; 36(23):7225-38. PubMed ID: 9188724
    [Abstract] [Full Text] [Related]

  • 18. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K, Suzuki N, Yokoyama F, Takaki S, Umezawa K, Higo J, Mochizuki M, Kikkawa Y, Oishi S, Utani A, Nomizu M.
    Biochemistry; 2007 Feb 20; 46(7):1952-60. PubMed ID: 17261031
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D.
    Am J Pathol; 1997 Feb 20; 150(2):653-66. PubMed ID: 9033278
    [Abstract] [Full Text] [Related]

  • 20. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
    Reynolds JJ, Meikle MC.
    J R Coll Surg Edinb; 1997 Jun 20; 42(3):154-60. PubMed ID: 9195805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.